The shared epitope is a marker of severity associated with selection for, but not with response to, infliximab in a large rheumatoid arthritis population

Lignende værker

• Shared epitope and rheumatoid arthritis severity: association with infliximab treatment in a postmarketing study
  af: Marotte, H, et al.
  Udgivet: (2003)
• The association between periodontal disease and joint destruction in rheumatoid arthritis extends the link between the HLA‐DR shared epitope and severity of bone destruction
  af: Marotte, H, et al.
  Udgivet: (2006)
• Rheumatoid arthritis and genetic markers in Syrian and French populations: different effect of the shared epitope
  af: Kazkaz, Leyla, et al.
  Udgivet: (2007)
• A 1-year case-control study in patients with rheumatoid arthritis indicates prevention of loss of bone mineral density in both responders and nonresponders to infliximab
  af: Marotte, Hubert, et al.
  Udgivet: (2007)
• Apolipoprotein A-I and platelet factor 4 are biomarkers for infliximab response in rheumatoid arthritis
  af: Trocmé, Candice, et al.
  Udgivet: (2009)